Domov › Rakovina vaječníkov › Pennsylvania › Philadelphia

Klinické štúdie Rakovina vaječníkov v meste Philadelphia, PA

44 štúdií pre Rakovina vaječníkov hľadá účastníkov v zariadeniach v meste Philadelphia a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Prebieha náborFáza 2/3

Thomas Jefferson University Hospital, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Prebieha náborFáza 2

Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Fox Chase Cancer Center, Philadelphia
a 4 ďalších

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Prebieha náborFáza 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Prebieha náborFáza 1

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06586957

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Prebieha nábor

University of Pennsylvania, Philadelphia

Vek 18 a viac · Ženy · Aktualizované 29. 9. 2026 · NCT05287451

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Prebieha náborFáza 2

University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia

Vek 18 a viac · Ženy · Aktualizované 29. 9. 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Prebieha náborFáza 2

Site 0232 - University of Pennsylvania, Philadelphia
Site 0178 - Thomas Jefferson University, Philadelphia

Vek 18 a viac · Ženy · Aktualizované 29. 9. 2026 · NCT05128825

Study of AVZO-021 in Patients With Advanced Solid Tumors

Prebieha náborFáza 1/2

Avenzo Therapeutics Recruiting Site, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05867251

DESTINY-PANTUMOUR04

Prebieha náborObservačná štúdia

Research Site, Philadelphia

Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Prebieha náborFáza 1/2

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Vek 18 a viac · Ženy · Aktualizované 24. 9. 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Prebieha náborFáza 3

University of Pennsylvania Hospital, Philadelphia
Jefferson Health Honickman Center, Philadelphia
Asplundh Cancer Pavilion, Willow Grove · 13 míľ odtiaľ

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Prebieha náborFáza 1

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Prebieha náborFáza 2

Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia

Vek 18 a viac · Ženy · Aktualizované 22. 9. 2026 · NCT07059845

Prehabilitation in High-risk Oncologic Surgery

Prebieha nábor

Fox Chase Cancer Center - Philadelphia, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07638410

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Prebieha náborFáza 1/2

University of Pennsylvania, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Prebieha náborFáza 3

Hospital of the University of Pennsylvania ( Site 0071), Philadelphia

Vek 18 a viac · Ženy · Aktualizované 17. 9. 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Prebieha náborFáza 3

Lankenau Medical Center, Wynnewood · 7 míľ odtiaľ

Vek 18 a viac · Ženy · Aktualizované 15. 9. 2026 · NCT07214779

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Prebieha náborObservačná štúdia

University of Pennsylvania, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Prebieha náborFáza 1

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07216105

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Prebieha náborFáza 1/2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Prebieha náborFáza 1

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06774963

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Prebieha náborFáza 1

SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07470853

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Prebieha náborFáza 1

Normunity Investigational Site, Philadelphia
Normunity Investigational Site, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

Prebieha náborObservačná štúdia

ACPMP, Springfield · 8 míľ odtiaľ

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT07769346

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Prebieha náborFáza 3

Site 0109, Philadelphia
Site 0113, Philadelphia
Site 0114, Willow Grove · 13 míľ odtiaľ

Vek 18 a viac · Ženy · Aktualizované 12. 8. 2026 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Prebieha nábor

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Fox Chase Cancer Center, Philadelphia
Lankenau Medical Center, Wynnewood · 7 míľ odtiaľ
a 5 ďalších

Vek 35 až 50 · Ženy · Aktualizované 7. 8. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Prebieha náborFáza 3

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
a 5 ďalších

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06580314

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1/2

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT04657068